19. NOTES PAYABLE

 

Notes payable at December 31, 2025 and 2024, were comprised of the following:

                          
    Collateral  Guarantors  Interest
rate
  Effective
rate(1)
  Due date  December 31,
2025
   December 31,
2024
 
AGREE secured construction loans, in default    AGREE hotels  -  9%  9%  January 1, 2026  $68,750,000   $68,750,000 
Circle 8 revolving credit facility    Circle 8 cranes with a book value of $25.6 million  -  9%  9%  June 16, 2026   7,205,000    13,126,000 
Circle 8 equipment financing notes    Circle 8 equipment with a book value of $3.2 million  -  6%  6%  Various dates through July 20, 2029   2,171,000    2,826,000 
15% term notes, in default    -  Milton C. Ault, III  15%  -  October 31, 2024   -    3,777,000 
ROI promissory note, in default    -  -  18%  36%  May 15, 2025   -    2,367,000 
Other ($0.9 million in default)    -  -  6%     Various   4,995,000    5,826,000 
Total notes payable                   $83,121,000   $96,672,000 
Less:                            
Unamortized debt discounts                    -    - 
Total notes payable, net                   $83,121,000   $96,672,000 
Less: current portion                    (82,055,000)   (95,768,000)
Notes payable – long-term portion                   $1,066,000   $904,000 

 

(1)Includes forbearance and extension fees and OID costs that are amortized to interest expense over the life of the notes.

 

Amendment to AGREE Secured Construction Loans

 

The AGREE secured construction loans with an original due date of January 1, 2025, were amended on February 2, 2025, whereby AGREE agreed to pay monthly installments of interest only based on an annualized interest rate of Term SOFR plus 4.75%. In addition, AGREE agreed to make principal payments of $1.0 million in June 2025 and $2.0 million in September 2025 and December 2025 with the balance due March 1, 2026. AGREE has failed to make timely interest payments per the amended payment terms.

 

Gain on Extinguishment of ROI Note Payable

 

During the year ended December 31, 2025, the Company recognized a gain on extinguishment of debt of $1.1 million related to the pay-off of an ROI note payable.

 

Notes Payable Maturities

 

Principal maturities of the Company’s notes payable, assuming the exercise of all extensions that are exercisable solely at the Company’s option, as of December 31, 2025 were:

      
Year     
2026   $82,055,000 
2027    488,000 
2028    354,000 
2029    224,000 
    $83,121,000 

 

Interest Expense

 

Interest expense includes amounts incurred on notes payable, convertible notes payable, and notes payable to related parties. The components of interest expense for the years ended December 31, 2025 and 2024 were as follows:

          
   For the Year Ended 
   December 31, 
   2025   2024 
Contractual interest expense  $11,153,000   $11,925,000 
Forbearance fees   505,000    2,214,000 
Amortization of debt discount   4,462,000    5,532,000 
Total interest expense  $16,120,000   $19,671,000 

 

Historical Timeline

Fiscal YearFiled
2025Apr 15, 2026Showing above
2024Apr 15, 2025

About Debt Disclosures

Debt disclosures detail a company's borrowing structure — the types of instruments, interest rates, maturity schedule, and covenant restrictions that define its financial obligations and flexibility. This section is essential for assessing refinancing risk, interest rate exposure, and the margin of safety against financial distress.

Key signals: the maturity schedule reveals concentration risk — large maturities within 1-2 years during tight credit markets can force dilutive refinancing or asset sales. Compare the fair value of debt against carrying amount to gauge whether the market views the company's credit risk differently than the balance sheet suggests. Watch covenant compliance disclosures for tightening cushions, especially leverage and interest coverage ratios. Variable-rate debt exposure quantifies sensitivity to interest rate changes. Secured versus unsecured mix affects recovery rates and future borrowing capacity. Compare net debt-to-EBITDA against industry peers and covenant limits to assess financial health.